RxDoctor Payments Data

Lisa Schavrien, PA

Surgical · Baton Rouge, LANPI 1851551360

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Baxter Healthcare at 29.4% of the total. 2025 is the largest year on record at $559, 2.6 times the $214 reported in 2021.

$1,887in general payments, 2019–2025

Across 34 payments — averaging $55.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$556
  • Bioventus LLC$182
  • Medtronic$163
  • Boston Scientific$149
  • Abbott$145
  • Amgen$124
  • plus $569 from 14 others

What the payments were for

  • Food & beverage$1,887100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,887 in reported general payments places this provider in the 75th percentile of 130 surgical providers in Louisiana.

See all surgical providers in Louisiana

Medicare billing

Part B allowed, 2024
$17,664
Medicare patients
66
Services billed
272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin115$1,201
Methocarbamol76$836
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen71$723
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen67$700
Cyclobenzaprine Hcl60$370
Pregabalin17$313
Tizanidine Hcl16$136
Cephalexin12$125
Naproxen14$95
Tramadol Hcl17$57
Meloxicam15$38

Paid to pharmacies, not to this prescriber.

Other surgical in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →